Eton Pharmaceuticals Inc. (ETON) Tops Q4 EPS by 1c

Eton Pharmaceuticals Inc. (NASDAQ: ETON) reported Q4 EPS of $0.19, $0.01 better than the analyst estimate of $0.18. Revenue for the quarter came in at $21.3 million versus the consensus estimate of $21.96 million.

For earnings history and earnings-related data on Eton Pharmaceuticals Inc. (ETON) click here.

You May Also Be Interested In

• Yatsen Holding (YSG) Reports Q2 Loss of $0.16
• Increasing unusual put option volume: IHI HBAN DBX FOXA EYPT CARR FEZ DT NVS ITB HWM TRIP
• Active options: AAPL NVDA TSLA MU AMZN META SPCX INTC MSFT ORCL